Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 94 15.2%
Current Price (11/20) $140.65
CAPS Rating (Rate this stock on CAPS) Foolcaps 3
Expected Income Statement
Current Sales 2,077.2
Sales Growth Forecast 13.3%
Net Profit Margin 45.7%
Projected Shares Outstanding 61.87
EPS - Five year Forecast $28.59
Average P/E Ratio 10.0
Projected Average Price $285.95
Price Appreciation (Annualized) 15.2%
Annual Dividend Yield 0.0%
Projected Annual Return 15.2%
Quality
Financial Strength 85 21.3
EPS Stability 94 23.6
Industry Sales Growth Rate 16.5% 10.0
Industry Net Profit Margin 29.0% 19.7
Calculated Quality Rating 74.7
Fool CAPS

Total Players

305 Outperforms
67 Underperforms
 

All-Stars (69)

54 Outperforms (78%)
15 Underperforms
 
Fundamental Data Updated: 09/06/2019

MIPAR 8.6%  
Sweet Spot 13.6% - 18.6%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 15.2%
BSTC 78 18.9%
REGN 80 22.5%
BIIB 82 13.0%
VRTX 56 18.8%

Top In Healthcare

Ticker Quality PAR
CMD 93 17.0%
JAZZ 94 15.2%
BSTC 78 18.9%
ALGN 98 12.8%
BAYRY 70 18.5%